Invention Grant
- Patent Title: High concentration medicant solutions for treating neurological disorders
-
Application No.: US16850859Application Date: 2020-04-16
-
Publication No.: US11433038B2Publication Date: 2022-09-06
- Inventor: Daniel J. Abrams , Thomas Joseph Anchordoquy
- Applicant: Cerebral Therapeutics, Inc.
- Applicant Address: US CO Aurora
- Assignee: Cerebral Therapeutics, Inc.
- Current Assignee: Cerebral Therapeutics, Inc.
- Current Assignee Address: US CO Aurora
- Agency: Mueting Raasch Group
- Main IPC: A61K31/19
- IPC: A61K31/19 ; A61K9/00 ; A61P25/18 ; A61P25/24 ; A61P25/08 ; A61K47/12 ; A61K45/06

Abstract:
Highly concentrated solutions are disclosed along with methods of inhibiting and/or ameliorating functional neurological disorders of the brain. The method may include administering directly to a brain of a subject a medicament multiple times over a time period of at least two days. The medicament may include a half-life of less than 2 hour in the cerebrospinal fluid. The method may include inhibiting and/or ameliorating a functional neurological disorder of the brain using the medicant.
Public/Granted literature
- US20200330412A1 HIGH CONCENTRATION MEDICANT SOLUTIONS FOR TREATING NEUROLOGICAL DISORDERS Public/Granted day:2020-10-22
Information query